Aller au contenu

Philippe Lachapelle

Professeur, Faculté de médecine et des sciences de la santé
FMSS Département de médecine - Service de pneumologie

Présentation

Expériences académiques

  • Pneumologue. (2018-). Université de Sherbrooke. Sherbrooke, Quebec, Canada.

Publications

Articles

  • Simon Couillard, Samuel Mailhot-Larouche, Fleur L. Meulmeester, Guy Brusselle, Philippe Lachapelle, Richard W. Beasley, Jacob K. Sont, Ewout W. Steyerberg, Ian D. Pavord, Njira Lugogo. (2025). Normal FEV1 without Reversibility in Asthma Trials: A Placebo Patient-Level Meta-Analysis. American Journal of Respiratory and Critical Care Medicine. DOI
  • Carlos Celis-Preciado, Samuel Lemaire-Paquette, Philippe Lachapelle, Simon Couillard. (2025). Reply to: Type 2 inflammatory biomarkers in asthma and COPD: what we think we know. European Respiratory Journal. DOI
  • Hao Wang, Nok Him Fung, Cristina Gamell, Naomi Woodman, Samantha Chan, Philippe Lachapelle, Ross Vlahos, Jonathan McQualter, Stavros Selemidis, Mara Galli, Nick Wilson, Jo Douglass, Katherine Monaghan, Angel F. Lopez, Catherine Owczarek, Steven Bozinovski. (2025). SignallingviaCD131 regulates pulmonary inflammation, alveolar cell death and emphysema in COPD. ERJ Open Research. DOI
  • Lauranne Pouliot, Laurence Désy, Sarah-Ève Lemieux, Carlos Andrés Celis-Preciado, Samuel Lemaire-Paquette, Martine Duval, Simon Leclerc, Félix-Antoine Vézina, Philippe Lachapelle, Simon Couillard. (2025). The carbon footprint of diagnostic delays in asthma. ERJ Open Research. DOI
  • Carlos Andrés Celis-Preciado, Simon Leclerc, Martine Duval, Dominic O. Cliche, Pierre Larivée, Samuel Lemaire-Paquette, Simon Lévesque, Andréanne Côté, Philippe Lachapelle, Simon Couillard. (2023). Phenotyping the Responses to Systemic Corticosteroids in the Management of Asthma Attacks (PRISMA): protocol for an observational and translational pilot study. BMJ Open Respiratory Research. DOI
  • Carlos Andrés Celis‐Preciado, Philippe Lachapelle, Simon Couillard. (2023). Exhaled nitric oxide (FeNO): Bridging a knowledge gap in asthma diagnosis and treatment. Clinical & Experimental Allergy. DOI
  • Philippe Lachapelle, Sulaiman Khadadah, Ryeyan Taseen, Sushmita Pamidi, R. John Kimoff. (2022). Scoring heart rate increases as a surrogate arousal marker on portable monitor studies for obstructive sleep apnea: Impact on diagnostic accuracy and clinical decision‐making. Journal of Sleep Research. DOI
  • Nur-Shirin Harun, Philippe Lachapelle, Gayan Bowatte, Caroline Lodge, George Braitberg, Louis Irving, Timothy Hinks, Shyamali Dharmage, Jo Douglass. (2021). 2016 Thunderstorm-asthma epidemic in Melbourne, Australia: An analysis of patient characteristics associated with hospitalization. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine. DOI
  • Simon Couillard, Louis-Philippe Boulet, Philippe Lachapelle. (2021). The controversial role of as-needed short-acting β2-agonist monotherapy in mild asthma: Short review of current guidelines. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine. DOI
  • (2019). Continued loss of asthma control following epidemic thunderstorm asthma. Asia Pacific allergy. DOI
  • Philippe Lachapelle, Juan Cascon, Sushmita Pamidi, R. John Kimoff. (2019). Accuracy of portable devices in sleep apnea using oximetry-derived heart rate increases as a surrogate arousal marker. Sleep and Breathing. DOI
  • (2019). Thunderstorm-triggered asthma: what we know so far. Journal of asthma and allergy. DOI
  • (2019). The 2016 Melbourne thunderstorm asthma epidemic: Risk factors for severe attacks requiring hospital admission. Allergy. DOI
  • Griffin, D.W.J., Huang, G.K.L., Lachapelle, P., Tong, S.Y.C., Mahanty, S. (2019). Mycobacterial mimicry in a man from Myanmar. Medical Journal of Australia. DOI
  • (2018). The Melbourne epidemic thunderstorm asthma event 2016: an investigation of environmental triggers, effect on health services, and patient risk factors. The Lancet. Planetary health. DOI
  • (2018). TSANZ Oral Presentations. Respirology. DOI
  • Lachapelle P, Li M, Douglass J, Stewart A. (2018). Safer approaches to therapeutic modulation of TGF-β signaling for respiratory disease. Pharmacology & therapeutics. DOI
  • (2017). Coal mine dust lung disease in the modern era. Respirology (Carlton, Vic.). DOI
  • Balachandran JS, Thomson CC, Sumter DB, Shelgikar AV, Lachapelle P, Pamidi S, Fall M, Lal C, Baba RY, Shah N, Fields BG, Sarmiento K, Butler MP, Shea SA, Baptiste JV, Sharkey KM, Wang T. (2016). ATS Core Curriculum 2016: Part I. Adult Sleep Medicine. DOI
  • (2012). Abstracts from the Conjoint Annual Meeting of L’Association des pneumologues de la province de Québec and le Réseau en santé respiratoire du FRSQ.